Literature DB >> 16815071

Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway.

Jasim Uddin1, Armando E Gonzalez, Robert H Gilman, Hector H Garcia, Manuela Verastegui, Lisa J Moore, Carlton A W Evans, Robert C Read, Jon S Friedland.   

Abstract

Neurocysticercosis, infection with larval Taenia solium, is a common, serious neuroparasitic infection. Larval degeneration results in inflammatory cell influx and granuloma formation which leads to clinical symptomatology. The role of chemokines in such cell influx is unknown. We demonstrate that monocyte stimulation by T. solium larval antigen (TsAg) results in a differential profile of CXCL8/IL-8 (146.5+/-8.5ng/ml after 24h), CCL2/MCP-1 (267+/-4 ng/ml after 48 h) and CCL3/MIP-1alpha (1.72+/-0.43 ng/ml after 8 h) secretion. There was coordinate mRNA accumulation reaching maximum at 1h for CCL3 and 2 h for CXCL8 and CCL2. TsAg induced maximal nuclear binding of p65, p50 and c-rel subunits of the transcriptional regulator NF-kappaB by 2 h. IkappaBalpha but not IkappaBbeta was degraded within 10 min before resynthesis by 2 h. Pre-treatment with the broad-spectrum NF-kappaB inhibitor pyrrolidine dithiocarbamate caused complete abrogation of TsAg-induced CCL2 secretion (p=0.005) and 91% reduction of CXCL8 secretion (p=0.0003). TsAg was unable to induce CXCL8 promoter activity in Toll-like receptor (TLR)-2 or TLR-4/MD-2 transfected HeLa cells in the absence of lectins or other adaptor molecules. In summary, our data demonstrate that TsAg induces chemokine secretion via specific pathways dependent on NF-kappaB but not TLR-4/TLR-2, and indicate a potential mechanism whereby larval degeneration results in brain inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815071     DOI: 10.1016/j.micinf.2006.02.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

1.  Is the presence of depression independent from signs of disease activity in patients with neurocysticercosis?

Authors:  Sergio Monteiro de Almeida; Solange Aparecida Gurjão
Journal:  J Community Health       Date:  2011-10

2.  Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy.

Authors:  Jasim Uddin; Armando E Gonzalez; Robert H Gilman; Lynette H Thomas; Silvia Rodriguez; Carlton A W Evans; Daniel G Remick; Hector H Garcia; Jon S Friedland
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

Review 3.  Immunology of Taenia solium taeniasis and human cysticercosis.

Authors:  H H Garcia; S Rodriguez; J S Friedland
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

4.  Severe cysticercal meningitis: clinical and imaging characteristics.

Authors:  Graciela Cárdenas; Helgi Jung; Camilo Ríos; Agnes Fleury; José Luís Soto-Hernández
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

5.  Comparison of monocyte gene expression among patients with neurocysticercosis-associated epilepsy, Idiopathic Epilepsy and idiopathic headaches in India.

Authors:  Vasudevan Prabhakaran; Douglas A Drevets; Govindan Ramajayam; Josephine J Manoj; Michael P Anderson; Jay S Hanas; Vedantam Rajshekhar; Anna Oommen; Hélène Carabin
Journal:  PLoS Negl Trop Dis       Date:  2017-06-16

Review 6.  The Role of Nuclear Factor Kappa B (NF-κB) in the Immune Response against Parasites.

Authors:  Piotr Bąska; Luke J Norbury
Journal:  Pathogens       Date:  2022-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.